Suicide in neurologic illness

被引:55
作者
David B. Arciniegas
C. Alan Anderson
机构
[1] University of Colorado Health Sciences Center,Neuropsychiatry Service, Departments of Psychiatry and Neurology
关键词
Multiple Sclerosis; Traumatic Brain Injury; Fluoxetine; Suicidal Ideation; Suicide Attempt;
D O I
10.1007/s11940-002-0013-5
中图分类号
学科分类号
摘要
The risk of attempted or completed suicide is increased in patients with migraine with aura, epilepsy, stroke, multiple sclerosis, traumatic brain injury, and Huntington’s disease. Contrary to the general perception that the risk of suicide among patients with Alzheimer’s disease and other dementing conditions is low, several reports suggest that the risk of suicide in these patients increases relative to the general population. Some patients at risk for neurologic disorders are also at increased risk for suicide; in particular, the risk of suicide is increased among persons at risk for Huntington’s disease, independent of the presence or absence of the Huntington’s gene mutation. The risk of attempted or completed suicide in neurologic illness is strongly associated with depression, feelings of hopelessness or helplessness, and social isolation. Additional suicide risk factors in persons with neurologic illness include cognitive impairment, relatively younger age (under 60 years), moderate physical disability, recent onset or change in illness, a lack of future plans or perceived meaning in life, recent losses (personal, occupational, or financial), and prior history of psychiatric illness or suicidal behavior. Substance dependence, psychotic disorders, anxiety disorders, and some personality disorders (eg, borderline personality disorder) may also contribute to increased risk of suicide among persons with neurologic illnesses. Identification and aggressive treatment of psychiatric problems, especially depression, as well as reduction of modifiable suicide risk factors among patients with neurologic illness is needed to reduce the risk of attempted and completed suicide in this population.
引用
收藏
页码:457 / 468
页数:11
相关论文
共 180 条
[61]  
Lundin A(1996)ECT in genetically confirmed Huntington’s disease J Neuropsychiatry Clin Neurosci 8 209-210
[62]  
Stenager EN(1992)Multiple sclerosis and ECT: possible value of gadoliniumenhanced magnetic resonance scans for identifying high-risk patients J Neuropsychiatry Clin Neurosci 4 145-151
[63]  
Stenager E(1993)Electroconvulsive therapy for depression after temporal lobectomy for epilepsy Convuls Ther 9 217-219
[64]  
Koch-Henriksen N(1998)Electroconvulsive therapy for epilepsy and major depression Am J Geriatr Psychiatry 6 180-183
[65]  
Stenager EN(1983)ECT in the treatment of a depressed adolescent with meningomyelocele, hydrocephalus, and seizures J Clin Psychiatry 44 385-386
[66]  
Koch-Henriksen N(2000)The benefits and risks of ECT for patients with primary dementia who also suffer from depression Int J Geriatr Psychiatry 15 729-735
[67]  
Stenager E(1998)Effectiveness of ECT in patients with parkinsonism J Neuropsychiatry Clin Neurosci 10 187-193
[68]  
Sadovnick AD(1999)Safety and efficacy of ECT in patients with head injury: a case series J Neuropsychiatry Clin Neurosci 11 32-37
[69]  
Eisen K(2001)Comparative outcomes for individual cognitive-behavior therapy, supportive-expressive group psychotherapy, and sertraline for the treatment of depression in multiple sclerosis J Consult Clin Psychol 69 942-949
[70]  
Ebers GC(undefined)undefined undefined undefined undefined-undefined